Retrospective study analyzes HDL-C levels in hidradenitis suppurativa, indicating its role in assessing disease severity.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder increasingly recognized as a systemic disease with significant metabolic comorbidity. Disturbances in lipid metabolism, particularly reduced high-density lipoprotein cholesterol (HDL-C), have been consistently reported in patients with HS. However, the extent to which HDL-C levels are associated with clinical characteristics, systemic inflammatory burden, and disease severity in HS remains insufficiently defined. In this retrospective single-center study, clinical and laboratory data were analyzed for 109 patients with HS and 109 age- and sex-matched healthy controls. Serum lipid parameters were compared between groups. Patients with HS were further stratified according to HDL-C status, and differences in demographic characteristics, clinical features, and laboratory indices were examined to assess the clinical relevance of reduced HDL-C in HS. Compared with healthy controls, patients with HS had a significantly higher body mass index (BMI), triglyceride (TG) concentrations and significantly lower HDL-C levels (p < 0.001). Among patients with HS, those with abnormal HDL-C levels exhibited significantly higher BMI, white blood cell count, plateletcrit, gamma-glutamyl transferase, and high-sensitivity C-reactive protein levels than those with normal HDL-C levels (p < 0.05). In addition, axillary involvement was significantly more frequent in the abnormal HDL-C group (p = 0.017). A higher proportion of Hurley stage III disease and higher IHS4 scores were observed in the HDL-C abnormal group. Patients with HS demonstrate a characteristic reduction in HDL-C that is associated with elevated systemic inflammatory markers and increased axillary involvement. These findings support HDL-C as a readily accessible indicator of inflammatory burden and disease severity in HS and highlight its potential value in clinical risk stratification.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: